Reactions Weekly

, Volume 1658, Issue 1, pp 186–186 | Cite as

Erlotinib

Various toxicities: case report
Case report
  • 32 Downloads

Reference

  1. Satankova M, et al. Effect of erlotinib in 2nd and 3rd line anticancer treatment in patients with squamous cell lung cancer-Case series. Klinicka Onkologie 30: 131-135, No. 2, Jan 2017. Available from: URL: http://doi.org/10.14735/amko2017131 [Czech; summarised from a translation] - CzechRepublicCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations